Related Experiment Video
Updated: Aug 8, 2026

A Preclinical Controlled Cortical Impact Model for Traumatic Hemorrhage Contusion and Neuroinflammation
Published on: June 10, 2020
[A clinico-immunological study in recurrent mild craniocerebral trauma in the acute period]
Insights
Repeated mild brain injuries worsen clinical and immune markers, indicating autoimmune reactions. Patients with repeated injuries are at higher risk for disease progression and require immunomodulating therapy.
Area of Science:
- Neuroscience
- Immunology
Background:
- Mild brain injury (MBI) can have lasting effects.
- Repeated injuries may exacerbate outcomes.
Purpose of the Study:
- To compare clinical and immunological parameters in patients with first-time versus repeated mild brain injury.
- To identify risk factors for disease progression after mild brain injury.
Main Methods:
- Comparative clinical assessments including X-ray, CT, echoencephalography, EEG, ECG, funduscopy, and lumbar puncture.
- Immunological evaluations of cellular and humoral immunity, and neurosensitization.
- Study involved 98 patients with first mild brain injury and 92 with repeated mild brain injury.
Main Results:
- Clinical and immunological parameters significantly worsened by week 3 in patients with repeated mild brain injury.
- Worsening parameters suggest the development of autoimmune autoaggressive reactions in sensitized individuals.
- Repeated mild brain injury patients demonstrated a higher risk for disease progression.
Conclusions:
- Repeated mild brain injury is associated with a heightened risk of disease progression due to autoimmune responses.
- Patients with repeated mild brain injury should be identified as a high-risk group.
- Immunomodulating therapy is recommended for patients with repeated mild brain injury to manage disease progression.
Abstract:
Comparative clinical (X-ray study, computed tomography, echoencephalography, electroencephalography, electrocardiography, examination of the fundus of the eye, lumbar puncture) and immunological (examination of cellular and humoral immunities, neurosensitization) studies were conducted in 98 patients with the first mild brain injury and 92 with repeated injury. Clinical and immunological parameters became worse in patients with repeated brain injury at week 3, which shows the development of autoimmune autoaggressive reactions in the sensitized body. These patients should be referred to as a risk group of disease progression and they should be given immunomodulating therapy.
More Related Videos
09:49Assessing Changes in Synaptic Plasticity Using an Awake Closed-Head Injury Model of Mild Traumatic Brain Injury
Published on: January 20, 2023
08:27Development of an Uncomplicated Mild Traumatic Brain Injury Model Modified by Weight-Drop Method and Evidenced by Magnetic Resonance Imaging
Published on: April 11, 2025